The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Enhancing myelin renewal reverses cognitive dysfunction in a murine model of Alzheimer’s disease
Open accessAbstract
Severe cognitive decline is a hallmark of Alzheimer's disease (AD). In addition to gray matter loss, significant white matter pathology has been identified in AD patients. Here, we characterized the dynamics of myelin generation and loss in the APP/PS1 mouse model of AD. Unexpectedly, we observed a dramatic increase in the rate of new myelin formation in APP/PS1 mice, reminiscent of the robust oligodendroglial response to demyelination. Despite this increase, overall levels of myelination are decreased in the cortex and hippocampus of APP/PS1 mice and postmortem AD tissue. Genetically or pharmacologically enhancing myelin renewal, by oligodendroglial deletion of the muscarinic M1 receptor or systemic administration of the pro-myelinating drug clemastine, improved the performance of APP/PS1 mice in memory-related tasks and increased hippocampal sharp wave ripples. Taken together, these results demonstrate the potential of enhancing myelination as a therapeutic strategy to alleviate AD-related cognitive impairment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nearly all have focused on the effect of amyloid plaques and Aβ on oligodendrocytes and myelin, partially describing secondary demyelination or hypomyelination.”
From Myelin dysfunction drives amyloid-β deposition in models of Alzheimer’s disease (2023) · cites this paper as [20]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Only a few studies have experimentally investigated oligodendrocytes and myelin in amyloid mouse models of AD20,21,41–43.”
From Myelin dysfunction drives amyloid-β deposition in models of Alzheimer’s disease (2023) · cites this paper as [20]
The cited source says what the claim attributes to it.
In the citing paper
“myelin alterations have been implicated in AD7–9”
From Oligodendrocytes produce amyloid-β and contribute to plaque formation alongside neurons in Alzheimer’s disease model mice (2024) · cites this paper as [7]
In the citing paper
“the disruption of myelin homeostasis adversely contributes to many neurological disorders, such as multiple sclerosis, leukodystrophies, and dementia.6,7,8,9,10”
From Neurons sequester the cholesterol-inhibiting TFEB in oligodendrocyte cytoplasm to safeguard myelination and neural function (2025) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
Morris water maze: procedures for assessing spatial and related forms of learning and memory
Vorhees, C. V., & Williams, M. T. (2006) · Nature Protocols · doi:10.1038/nprot.2006.116 · Cited by 4,629
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204
Scheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01124-1 · Cited by 3,125
Single-cell transcriptomic analysis of Alzheimer’s disease
Mathys, H., Davila-Velderrain, J., Peng, Z., Gao, F., Mohammadi, S., Young, J. Z., Menon, M., He, L., Abdurrob, F., Jiang, X., et al. (2019) · Nature · doi:10.1038/s41586-019-1195-2 · Cited by 2,568
The Cellular Phase of Alzheimer’s Disease
De Strooper, B., & Karran, E. (2016) · Cell · doi:10.1016/j.cell.2015.12.056 · Cited by 1,990
Hippocampal sharp wave-ripple: A cognitive biomarker for episodic memory and planning
Buzsáki, G. (2015) · Hippocampus · doi:10.1002/hipo.22488 · Cited by 1,759
Oligodendroglia metabolically support axons and contribute to neurodegeneration
Lee, Y., Morrison, B. M., Li, Y., Lengacher, S., Farah, M. H., Hoffman, P. N., Liu, Y., Tsingalia, A., Jin, L., Zhang, P.-W., et al. (2012) · Nature · doi:10.1038/nature11314 · Cited by 1,664
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Remyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–346 of 346
Griffin, A., Bowles, T., Solis, L., Railey, T., Beauti, S., Robinson, R., Spencer, S.-K., Shaffery, J. P., & Wallace, K. L. (2024) · Figshare · doi:10.6084/m9.figshare.26698313
Shao, W., Zhu, T., Xiong, X., Xiong, Y., & Zhang, Q. (2026) · Behavioural Brain Research · doi:10.1016/j.bbr.2026.116057
Wang, Y., Zhu, M., Park, J., Kim, H. K., Ge, X., Chen, X., Chen, B., Ding, S., Lin, W., & Guo, F. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.29.702669
Chen, X., Cai, Y., Chen, Y., Li, M., Zhao, M., Jiang, M., Lin, S., Tang, B., Zhang, C., Yu, G., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-8000305/v1
Self-citationSarrazin, N., Arab, R., Cordano, C., Brazhnikova, E., Chazot, J., Arcizet, F., Bachelin, C., Langui, D., Bennett, D. J., Abdelhak, A., et al. (2026) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.2520161123
Wellman, S. M., Guzman, K., Suematsu, N., Thai, T. T. D., Tung, T.-H., Padilla, C. G., Sridhar, S., Chen, K., Cambi, F., & Kozai, T. D. Y. (2026) · Journal of Neural Engineering · doi:10.1088/1741-2552/ae4d8b · Cited by 1
Huang, C., Han, Y., He, J., Ma, W., Chen, Y., Dong, Z., Cheng, X., Lu, C., & Gu, X. (2026) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00789
Zhang, Z., Zhang, X., Wang, Y., Li, Y., Ding, G., Tong, H., Xu, J., Li, C., Wang, X., & Gu, H. (2026) · Experimental Eye Research · doi:10.1016/j.exer.2026.110999
Zhang, J., Xiao, Y., Li, A., Ye, J., Zhao, X., Fan, X., & Lu, X. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.04.021
Neurotransmitter-activated GPCR signaling in myelin plasticity
Cimadevila, M., & Matute, C. (2026) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2026.04.005
Almas, S., Washakh, R. M. A., Waque, R. M. U., Almas, N., & Valdes-Sosa, P. A. (2026) · Occupational Diseases and Environmental Medicine · doi:10.4236/odem.2026.142011
Glycolysis: The Bridge Between Cellular Interaction and Alzheimer’s Disease
Lei, Q., He, Y., & Fang, B. (2026) · Biomolecules · doi:10.3390/biom16060796
Microenvironmental Regulation of Central Nervous System Myelination and Remyelination
Wang, Y., Tan, L., Lao, L., Huang, X., Zhang, S., & Sun, H. (2026) · Journal of Integrative Neuroscience · doi:10.31083/jin43257
Lin, H., Zhang, Y., Ni, R., Wang, M., Men, J., Ge, J., Lu, J., Wang, J., Zhang, H., Yang, Y., et al. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-02098-1
Ultrashort echo time magnetization transfer imaging of myelin in APP knock-in mice
Wang, J., Athertya, J., Cheng, X., Patel, A., Chan, N., Liu, B., Tang, Q., Chang, E. Y., Wang, S., Ma, Y., et al. (2026) · NeuroImage · doi:10.1016/j.neuroimage.2026.122040
Liu, Y., Wang, S., Liu, H., Liang, G., Xu, Z. S., & Meng, Q. (2026) · Research Square · doi:10.21203/rs.3.rs-9885354/v1
Yéfimova, M., Cantereau, A., Penaud, N., Barthelemy, A., Berkati, A.-K., Béré, E., Meunier, A.-C., Cosquer, B., Messaddeq, N., Decraene, C., et al. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106872
Inhibiting fear memory recall-induced oligodendrogenesis rescues PTSD-like behaviors
Feng, J., Huang, N.-X., Liu, K., Fan, Y.-C., Chen, J., Zhao, Y.-B., Yu, B., Fu, Q.-F., Mei, F., Wang, F., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03688-z
Self-citationBeyond gray matter: unveiling the critical role of white matter in Alzheimer's disease
Gao, K., Bao, J., 宋友军, Lin, C., Iturria‐Medina, Y., Biswal, B. B., & Wang, P. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111816
Chen, Z., Yang, K., Lin, F., Tang, W., Shi, Y., Zhou, S., Liu, J. S., & You, Y. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103229
Liu, S., Chen, W., Chen, X. H., Cai, Y., Cheng, L., Guo, H., Lin, F., Kang, Y., Wang, F., ZHAO, Y., et al. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107519
Self-citationMechanisms of autophagy–lysosome pathway impairment in Alzheimer's disease
Lü, K., Lu, Y., Tang, R., Dong, X., Zhuang, P., Gao, Y., Cheng, M., Wang, Y., & Wang, Y. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261460879
Plaque-associated oligodendrocyte proteostatic failure underlies myelin loss in Alzheimer’s diseasePreprint
Shin, J., Joshi, N., Miller, B., Vellarikkal, S., Huang, J., Wu, F., Cui, Y., Murali, A., Chason, J., Campbell, C. S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.08.737318
Hepatic Orosomucoid 2 aggravates demyelination and drives microglial DAM-like activation
Bi, H., Xu, Y., Xu, M., Zhang, N., Li, X., Chen, C., 郑明华, Lü, Y., Shi, W., & Wang, Q. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03988-9
Activation and increased hippocampal GPR55 prevents cognitive deficits in male APP/PS1 mice
Liang, Y., Zhi, T., Fan, B., Wu, Y., Wu, L., Xie, Z., Yang, Y., Mu, R., & Wu, X. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.111129
The influence of histamine and antihistamines on microglial regulation and neuroinflammation
Pehar, M., Westhoff, J., Fischer, D., & Kulka, M. (2026) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2025-0317
Dai, Y., Xu, C., Luo, H., Liu, Z.-Y., Meng, G., Li, J., Yu, A., Chen, X., Gao, X., Zhang, X., et al. (2026) · Glia · doi:10.1002/glia.70217
Self-citationHui, S.-W., Gao, X., Yu, B., Lei, Q., Liu, Z.-Y., Wu, S.-L., Cheng, Y.-J., Chen, T., Xiao, L., Li, T., et al. (2026) · Glia · doi:10.1002/glia.70206
Self-citationWang, X., Liu, Y., Liu, J., Wang, R., Zheng, J., Deng, Z., Song, K., Zhang, D., Wang, C., Zhu, K., et al. (2026) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2026.109675
Yu, J., Qi, W., Li, F., Chang, B., Wang, Z., Kan, Y., Yu, Y., & Yu, Y. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111892
Yu, H., Zhang, C.-Y., Cai, Y., Liu, Y., Wu, N., Wang, W.-J., Cai, G., & Wang, Y.-C. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115958
Xiong, Y.-Q., Yin, D., Qi, W.-B., Zhao, C.-R., Wang, X., Yan, X.-W., Yang, Z., Zhang, J., Li, Y.-X., Xia, B.-J., et al. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115984
Self-citationJerome, K., Gibson, B. M., Gorr, M. W., Schwieterman, N. A., Cohen, M. D., Wold, L. E., & Combs, C. K. (2026) · Journal of Immunotoxicology · doi:10.1080/1547691x.2026.2722654
Altered oligodendrocyte function promotes cognitive decline in aging
(2026) · Nature Medicine · doi:10.1038/s41591-026-04630-0
Targeting hormone treatment for the brain in menopause
Itoh, N., Itoh, Y., Patil, R., Till, C., Smith, M., Schwartz, J., Davis, B., Oberman, E., Romeroso, B. D., & Voskuhl, R. R. (2026) · Scientific Reports · doi:10.1038/s41598-026-65603-4
Deng, S., Gao, S., Zhou, C., Lan, Z., Li, H., Chen, J., Xu, Y., Li, J., Liu, P., Zhang, S., et al. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.71150 · Cited by 1
Self-citationOligodendrocytes in central nervous system health and disease
Ryan, L. J., & Miron, V. E. (2026) · Cell · doi:10.1016/j.cell.2026.08.003
Huang, L., Cheng, P., Liu, G., Xiang, Y., Hong, Z., & Le, W. (2026) · MedComm · doi:10.1002/mco2.71017
Pan, T., Huang, Y., Zhang, J., Tian, S., Li, Z., Li, X., Zhang, Y., Wang, D., Ye, S., Jin, M., et al. (2026) · Advanced Science · doi:10.1002/advs.78031
Fan, T., Wei, C., Chen, W., Li, S., Wang, J., Lu, Y., & Renshi, X. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1915475
Extracellular vesicles: Multi-source regulatory mechanisms in hippocampal homeostasis
Liu, Q., & Guo, L. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.107015
Xu, M., Bai, Y., Zeng, X., Tan, C., Lai, Y., & Wang, Y. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261490479
Singh, R. K., Banerjee, C., & Mehan, S. (2026) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-026-10321-x
Post-traumatic dementia: Advances in understanding neurodegenerative mechanisms
He, X.-J., Wang, H., & Zhang, Y. (2026) · Chinese Medical Sciences Journal · doi:10.1016/j.cmsj.2026.08.001
Metadata
- Authors
- Chen, J.-F., Liu, K., Hu, B., Li, R.-R., Xin, W., Chen, H., Wang, F., Chen, L., Li, R.-X., Ren, S.-Y., Xiao, L., Chan, J. R., & Mei, F.
- Affiliations
- Army Medical University (CN)
- University of California, San Francisco (US)
- Corresponding author
- Xiao, Lan
- Chan, Jonah R.
- Mei, Feng
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 109
- Issue
- 14
- Pages
- 2292-2307.e5
- ISSN
- 0896-6273 (ISSN-L)
- PMC
- PMC8298291
- OpenAlex
- W3169884592
- Cited by
- 346
- References
- 71
- Citations by year
- 2026: 55 · 2025: 75 · 2024: 70 · 2023: 75 · 2022: 52 · 2021: 17
- FWCI
- 33.58
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 385 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Neuron (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Chongqing Science and Technology Commission
- Doctor Miriam and Sheldon G Adelson Medical Research Foundation
- National Institutes of Health
- Chongqing Municipal Education Commission
- National Institute of Neurological Disorders and Stroke
- National Natural Science Foundation of China
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, myelination, white matter pathology, APP/PS1 mice, oligodendrocytes, demyelination, M1 muscarinic receptor, clemastine, cognitive impairment, memory, hippocampal ripples, treatment options
- MeSH terms
- Alzheimer Disease, Animals, Cerebral Cortex, Disease Models, Animal, Mice, Transgenic, Myelin Sheath, Amyloid beta-Protein Precursor, Maze Learning, Mice, Presenilin-1, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
